Moshe Giladi - 26 Jul 2023 Form 3 Insider Report for NovoCure Ltd (NVCR)

Reporting relationship
Chief Science Officer
Issuer ticker
NVCR
Reported as of
26 Jul 2023
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
20 Dec 2023, 16:23:38 UTC
Next SEC filing
29 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Steven Robbins, as attorney in fact for Giladi, Moshe

Key filing fact

Moshe Giladi filed Form 3 for NovoCure Ltd (NVCR) on 20 Dec 2023.

Key facts

  • This page summarizes Moshe Giladi's Form 3 filing for NovoCure Ltd (NVCR).
  • 0 reported transactions and 10 derivative rows are listed below.
  • Accepted by SEC: 20 Dec 2023, 16:23.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NVCR holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,008
Date
26 Jul 2023
Ownership
Direct
NVCR holding

Restricted Share Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,496
Date
26 Jul 2023
Ownership
Direct
Footnotes
F1
NVCR holding

Restricted Share Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,983
Date
26 Jul 2023
Ownership
Direct
Footnotes
F2
NVCR holding

Restricted Share Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,653
Date
26 Jul 2023
Ownership
Direct
Footnotes
F3
NVCR holding

Restricted Share Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
154
Date
26 Jul 2023
Ownership
Direct
Footnotes
F4
NVCR holding

Restricted Share Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
353
Date
26 Jul 2023
Ownership
Direct
Footnotes
F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NVCR holding Derivative

Stock Options (Right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
26 Jul 2023
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
1,951
Exercise price
$153.09
Footnotes
F6
NVCR holding Derivative

Stock Options (Right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
26 Jul 2023
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
831
Exercise price
$107.73
Footnotes
F7
NVCR holding Derivative

Stock Options (Right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
26 Jul 2023
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
7,693
Exercise price
$83.77
Footnotes
F8
NVCR holding Derivative

Stock Options (Right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
26 Jul 2023
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
4,346
Exercise price
$80.59
Footnotes
F9
NVCR holding Derivative

Stock Options (Right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
26 Jul 2023
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
833
Exercise price
$77.49
Footnotes
F10
NVCR holding Derivative

Stock Options (Right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
26 Jul 2023
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
10,804
Exercise price
$76.97
Footnotes
F11
NVCR holding Derivative

Stock Options (Right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
26 Jul 2023
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
2,779
Exercise price
$69.37
Footnotes
F12
NVCR holding Derivative

Stock Options (Right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
26 Jul 2023
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
2,822
Exercise price
$47.04
Footnotes
F10
NVCR holding Derivative

Stock Options (Right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
26 Jul 2023
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
3,451
Exercise price
$21.15
Footnotes
F10
NVCR holding Derivative

Stock Options (Right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
26 Jul 2023
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
6,875
Exercise price
$7.15
Footnotes
F10
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 12 footnotes

Footnote F1

Represents restricted share units that are scheduled to vest in equal installments on February 28, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.

Footnote F10

Currently exercisable.

Footnote F11

Options to buy 10,804 ordinary shares will vest in equal installments on each of February 28, 2024, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.

Footnote F12

Options to buy 2,779 ordinary shares, 2,085 shares of which are currently exercisable and the remainder will vest on March 3, 2024, subject to the reporting person's continued employment through such date.

Footnote F2

Represents restricted share units that are scheduled to vest in equal installments on May 3, 2024 and 2025, subject to the reporting person's continued employment through such dates.

Footnote F3

Represents restricted share units that are scheduled to vest in equal installments on March 1, 2024 and 2025, subject to the reporting person's continued employment through such dates.

Footnote F4

Represents restricted share units that are scheduled to vest in equal installments on November 2, 2024, subject to the reporting person's continued employment through such date.

Footnote F5

Represents restricted share units that are scheduled to vest in equal installments on March 2, 2024, subject to the reporting person's continued employment through such date.

Footnote F6

Options to buy 1,951 ordinary shares, 976 shares of which are currently exercisable and the remainder will vest in equal installments on each of March 2, 2024 and 2025, subject to the reporting person's continued employment through such dates.

Footnote F7

Options to buy 831 ordinary shares, 416 shares of which are currently exercisable and the remainder will vest in equal installments on each of November 2, 2024 and 2025, subject to the reporting person's continued employment through such dates.

Footnote F8

Options to buy 7,693 ordinary shares, 1,924 shares of which are currently exercisable and the remainder will vest in equal installments on each of May 3, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.

Footnote F9

Options to buy 4,346 ordinary shares, 1,087 shares of which are currently exercisable and the remainder will vest in equal installments on each of March 1, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .